Craft

Inari Medical

Stock Price

$43.3

2024-08-23

Market Capitalization

$2.5 B

2024-08-23

Revenue

$493.6 M

FY, 2023

Inari Medical Summary

Company Summary

Overview
Inari Medical (formerly known as Inceptus Newco1) is a medical device company focused on developing products to treat and transform patients suffering from venous diseases. Its products include ClotTriever, a device designed for the removal of a blood clot from peripheral blood vessels, the FlowTriever thrombectomy system for the treatment of pulmonary embolism, the FlowStasis suture retention device designed to address venous access site closure, etc.
Type
Public
Status
Active
Founded
2011
HQ
Irvine, CA, US | view all locations
Website
https://www.inarimedical.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Bill Hoffman
  • Mitch Hill

    Mitch Hill, Chief Financial Officer

  • Thomas Tu

    Thomas Tu, Chief Medical Officer

  • Drew Hykes

    Drew Hykes, Chief Executive Officer, President and Director

Operating MetricsView all

Procedures Performed (PE Treatment)

3.3K
94.1%

Q3, 2021

Procedures Performed (DVT Treatment)

3.4K
70.0%

Q3, 2021

Procedures Performed

6.7K
81.1%

Q3, 2021

LocationsView all

1 location detected

  • Irvine, CA HQ

    United States

    6001 Oak Canyon, Suite 100

Inari Medical Financials

Summary Financials

Revenue (Q2, 2024)
$145.8M
Gross profit (Q2, 2024)
$125.8M
Net income (Q2, 2024)
($31.3M)
Cash (Q2, 2024)
$70.1M
EBIT (Q2, 2024)
($22.4M)
Enterprise value
$2.5B

Footer menu